Voyager 1 and 2 have traveled billions of miles over nearly half a century. NASA intends the Voyager program to continue its historic exploration for at least another few years. But after nearly half ...
LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. An illustration of the Voyager 2 spacecraft exploring space beyond the solar system. | Credit: ...
- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s ...
- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial ...
'We realize that Voyager means a lot to people and we are doing our best to keep them going for as long as possible.' By Andrew Paul Published Dec 14, 2023 11:35 AM EST Get the Popular Science daily ...
- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback